Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates ...

Yatiri Bio Accurately Predicts AML Drug Response in Blinded Study Using Foghorn’s FHD-286

A demonstrated 100% concordance between biomarker-guided predictions from pre-treatment patient samples and clinical outcomes ...
GEN

Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML

Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...
News Medical

Scientists develop mouse model to gain new insights into genetic mechanisms underlying AML

A novel mouse model of a highly lethal form of acute myeloid leukemia (AML) offers a new tool for scientists working to better understand this disease and research new therapeutic targets. Scientists ...